A novel experimental vaccine against the nipah virus has succeeded in its first major test in humans; it has been shown to be ...

A single dose of Immutep’s MS therapy, IMP761, was well tolerated and reduced T-cell activity for up to 23 days in healthy ...

Human immunodeficiency virus (HIV) infections are still fairly common and an estimated 40 million people worldwide are ...

Scientists present a new approach that could empower the immune system to combat cancer cells and pave the way for new treatments for this deadly ...

RIKEN researchers have discovered how right-handed molecules in our cells can give rise to cells that are not symmetrical ...

This article explores how single-cell multiomics and spatial transcriptomics are illuminating early pregnancy, uncovering ...

From vitamin C to your microbiome and mindset, the latest science of immunity is often counterintuitive. Here's how to give ...

Have a question for 25-year Vermilion County beat writer Jennifer Bailey? Submit them here and she'll respond each Thursday.

An NIH scientist’s maverick approach reveals legal, ethical, moral, scientific and social challenges to developing potentially life-saving vaccines.

Genetic alterations lie at the heart of cancer development, but scientists may have been overlooking a powerful driver of these changes—the everyday nutrients that feed our cells.

Here are the 10 most-read news stories about HMS-led discoveries in 2025.

Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before ...